Stayble Therapeutics
Current Promotions
No video available
Get in Touch
About
Stayble is a clinical stage pharmaceutical company developing the injectable treatment STA363 for disc hernia. The treatment is aimed at patients whose back pain persists after physiotherapy and painkillers. The injection is given once, and the effect is expected to remain throughout the entirety of the patient's life and to require minimal rehabilitation.
The Company's focus is set upon the continued clinical development of the ongoing clinical phase 1b study. Stayble's vision is to develop STA363 as a new standard treatment for patients suffering from pain caused by disc hernia.
Keywords
pharmaceutical development & chronic low back pain
Amenities
No amenities listed yet
Upcoming Events
No upcoming events scheduled
Frequently Asked Questions
No FAQs available for this business.
Reviews
No reviews yet. Be the first to review!
Social Links
No social media links available
Photo Gallery
No photos available
Contact Information
Business Info
Location
Business Hours
Business hours not available
Own This Business?
Unclaimed
Take control of your business page to update information, respond to reviews, and more.
Claim This Business